Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311

類似資料

• Preclinical evaluation of novel imidazoacridinone derivatives with potent activity against experimental colorectal cancer.
  著者:: Burger, A. M., 等
  出版事項: (1996)
• Cell killing by the novel imidazoacridinone antineoplastic agent, C-1311, is inhibited at high concentrations coincident with dose-differentiated cell cycle perturbation.
  著者:: Lamb, J., 等
  出版事項: (1996)
• CYP3A4 overexpression enhances apoptosis induced by anticancer agent imidazoacridinone C-1311, but does not change the metabolism of C-1311 in CHO cells
  著者:: Pawłowska, Monika, 等
  出版事項: (2014)
• Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
  著者:: Roizin-Towle, L. A., 等
  出版事項: (1981)
• Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells
  著者:: Niemira, Magdalena, 等
  出版事項: (2020)